Analyst Ratings for Hemab Therapeutics Holdings (COAG)
COAG Rating Summary
COAG Price Target Summary
- Highest: $60.00 (H.C. Wainwright)
- Lowest: $36.00 (Goldman Sachs)
- Average: $50.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$50.40 (+68.3%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/12/2026 | Rodman & Renshaw | Michael King Jr. | New Coverage | Buy (N/A) |
56.00 (N/A) |
31.62 (29.94) |
-5.31% | Details |
| 6/17/2026 | H.C. Wainwright » Updated 8/12/2026 |
Emily Bodnar | New Coverage | Buy (N/A) |
60.00 (52.00) |
25.51 (29.94) |
17.37% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
